
  
    
      
        Background_NNP
        The_DT fibromyalgia_NN syndrome_NN (_( FMS_NNP )_) is_VBZ characterized_VBN by_IN wide_JJ
        spread_NN pain_NN in_IN the_DT body_NN ,_, associated_VBN with_IN particular_JJ tender_NN
        points_NNS [_NN 1_CD 2_CD ]_NN ._. It_PRP is_VBZ often_RB accompanied_VBN by_IN unrestorative_JJ
        sleep_NN patterns_NNS ,_, fatigue_NN ,_, headaches_NNS ,_, irritable_JJ bowel_NN and_CC
        bladder_NN syndrome_NN ,_, morning_NN stiffness_NNS ,_, paresthesias_NNS ,_, anxiety_NN ,_,
        and_CC depression_NN [_NN 2_CD 3_CD ]_NN ._. The_DT prevalence_NN rate_NN is_VBZ about_IN 2_CD %_NN in_IN
        the_DT general_JJ population_NN ,_, 3_CD ._. 9_CD %_NN of_IN women_NNS ages_NNS 20_CD -_: 40_CD and_CC 5_CD ._. 8_CD %_NN
        of_IN women_NNS ages_NNS 40_CD -_: 60_CD [_NN 4_CD ]_NN ,_, and_CC as_RB high_JJ as_IN 8_CD %_NN in_IN women_NNS ages_NNS
        55_CD -_: 64_CD [_NN 5_CD ]_NN ._. FMS_NNP is_VBZ more_RBR prevalent_JJ in_IN women_NNS than_IN men_NNS ,_, in_IN
        about_IN a_DT 3_CD :_: 1_CD ratio_NN [_NN 5_CD ]_NN ._. People_NNS who_WP suffer_VBP from_IN FMS_NNP have_VBP a_DT
        disability_NN index_NN comparable_JJ to_TO that_DT of_IN patients_NNS with_IN
        rheumatoid_NN arthritis_NN [_NN 6_CD ]_NN while_IN disease_NN severity_NN was_VBD worse_JJR
        than_IN Sjogren_NNP 's_POS syndrome_NN [_NN 7_CD ]_NN ._. The_DT natural_JJ course_NN of_IN FMS_NNP
        may_MD include_VB some_DT symptomatic_JJ relief_NN [_NN 8_CD ]_NN ,_, but_CC many_JJ
        symptoms_NNS remain_VBP essentially_RB unchanged_JJ after_IN 7_CD years_NNS of_IN
        follow_VB up_RB [_NN 9_CD ]_NN ._.
        Treatments_NNP for_IN FMS_NNP include_VBP medications_NNS (_( amitriptyline_NN
        and_CC fluoxetine_NN most_RBS common_JJ )_) ,_, nutritional_JJ supplements_NNS (_( malic_JJ
        acid_NN ,_, s-adenosyl_JJ methionine_NN ,_, 5_CD -_: hydroxytryptophan_NN )_) ,_, and_CC
        physical_JJ therapies_NNS (_( cardiovascular_JJ training_NN ,_, stretching_VBG ,_,
        electroacupuncture_NN )_) ,_, and_CC cognitive-behavior_JJ therapy_NN
        [_NN reviewed_VBN in_IN [_NN 10_CD 11_CD 12_CD ]_NN ]_NN ._. FMS_NNP patients_NNS frequently_RB use_VBP
        alternative_JJ therapies_NNS ,_, indicating_VBG dissatisfaction_NN ,_, or_CC
        ineffectiveness_NN of_IN traditional_JJ medical_JJ therapy_NN [_NN 13_CD ]_NN ._.
        FMS_NNP engulfs_NNS patients_NNS in_IN a_DT downward_JJ spiral_NN of_IN
        unrestorative_JJ sleep_NN ,_, chronic_JJ pain_NN ,_, fatigue_NN ,_, inactivity_NN ,_, and_CC
        depression_NN ._. Each_DT symptom_NN reinforces_VBZ the_DT others_NNS ,_, making_VBG it_PRP
        difficult_JJ to_TO break_VB out_IN of_IN the_DT cycle_NN ._. A_DT 3_CD -_: week_NN vegetarian_NN
        diet_NN improved_VBD subjective_JJ well_RB being_VBG in_IN FMS_NNP patients_NNS ,_, along_IN
        with_IN significant_JJ reductions_NNS in_IN serum_NN peroxides_NNS ,_, plasma_NN
        fibrinogen_NN ,_, apolipoproteins_NNS A_DT and_CC B_NNP ,_, and_CC serum_NN total_JJ
        cholesterol_NN [_NN 14_CD ]_NN ._. A_DT "_'' living-foods_JJ "_'' vegan_NN diet_NN was_VBD used_VBN
        in_IN a_DT 3_CD -_: month_NN non-randomized_JJ controlled_VBN study_NN of_IN FMS_NNP
        subjects_NNS [_NN 15_CD ]_NN ._. In_IN the_DT intervention_NN group_NN there_EX were_VBD
        significant_JJ improvements_NNS in_IN pain_NN scores_NNS ,_, quality_NN of_IN sleep_NN ,_,
        morning_NN stiffness_NNS ,_, health_NN assessment_NN questionnaire_NN scores_NNS ,_,
        and_CC general_JJ health_NN questionnaire_NN ._. These_DT studies_NNS ,_, along_IN with_IN
        anecdotal_JJ evidence_NN that_IN we_PRP have_VBP gathered_VBN ,_, indicate_VBP that_IN a_DT
        mostly_RB raw_JJ food_NN vegetarian_NN diet_NN is_VBZ helpful_JJ in_IN breaking_VBG the_DT
        cycle_NN of_IN suffering_NN of_IN FMS_NNP patients_NNS ._.
        In_IN this_DT study_NN we_PRP utilized_JJ a_DT pure_JJ vegetarian_NN diet_NN
        composed_VBN mostly_RB of_IN common_JJ fruits_NNS ,_, vegetables_NNS ,_, nuts_NNS ,_, tubers_NNS ,_,
        carrot_NN juice_NN ,_, and_CC dehydrated_JJ barley_NN grass_NN juice_NN while_IN
        tracking_VBG participants_NNS '_POS FMS_NNP status_NN during_IN a_DT 7_CD -_: month_NN period_NN
        of_IN time_NN ._.
      
      
        Methods_NNP
        
          Subjects_NNP
          Subjects_NNP were_VBD recruited_VBN from_IN a_DT local_JJ fibromyalgia_NN
          support_NN group_NN ,_, by_IN notice_NN of_IN the_DT study_NN in_IN a_DT bi-yearly_JJ
          newsletter_NN ,_, and_CC by_IN word_NN of_IN mouth_NN ._. An_DT informed_VBN consent_NN
          document_NN explaining_VBG the_DT study_NN and_CC the_DT risks_NNS and_CC benefits_NNS
          of_IN participation_NN was_VBD given_VBN to_TO each_DT potential_JJ subject_NN ._.
          Written_VBN consent_NN was_VBD obtained_VBN from_IN subjects_NNS before_IN
          participation_NN ._. The_DT study_NN was_VBD conducted_VBN in_IN accord_NN with_IN the_DT
          ethical_JJ standards_NNS of_IN the_DT Helsinki_NNP Declaration_NNP of_IN 1975_CD as_IN
          revised_VBN in_IN 1983_CD ._.
          Subjects_NNP were_VBD required_VBN to_TO have_VB a_DT previous_JJ diagnosis_NN of_IN
          FMS_NNP by_IN a_DT rheumatologist_NN ,_, using_VBG the_DT American_NNP College_NNP of_IN
          Rheumatology_NNP criteria_NNS of_IN at_IN least_JJS 11_CD of_IN 18_CD tender_NN points_NNS
          being_VBG painful_JJ upon_IN palpation_NN ._. Subjects_NNP underwent_VBD a_DT
          physical_JJ examination_NN upon_IN entering_VBG the_DT study_NN ,_, including_VBG
          the_DT tender_NN point_NN survey_NN ._.
          Subjects_NNP were_VBD encouraged_VBN to_TO continue_VB with_IN any_DT
          medication_NN for_IN sleep_NN or_CC pain_NN ._. It_PRP was_VBD believed_VBN that_IN this_DT
          would_MD allow_VB the_DT best_JJS comparison_NN between_IN initial_JJ and_CC final_JJ
          conditions_NNS ,_, with_IN as_IN few_JJ variables_NNS changing_VBG as_IN possible_JJ ._.
          Subjects_NNP and_CC their_PRP$ prescribing_VBG physicians_NNS made_VBD all_DT
          medication_NN decisions_NNS ._. The_DT investigators_NNS in_IN this_DT study_NN had_VBD
          no_DT control_NN of_IN medication_NN usage_NN ._.
        
        
          Diet_NNP implementation_NN
          Subjects_NNP were_VBD supplied_VBN with_IN books_NNS published_VBN by_IN
          Hallelujah_NNP Acres_NNP ,_, Inc_NNP ._. (_( 
          God_NNP 's_POS Way_NN to_TO Ultimate_NNP Health_NNP ,_, Recipes_NNP
          for_IN Life_NNP ._. ._. ._. from_IN God_NNP 's_POS Garden_NNP ,_, 21_CD Days_NNS to_TO health_NN the_DT
          Hallelujah_NNP diet_NN way_NN )_) and_CC informational_JJ pamphlets_NNS ._.
          Instructions_NNP were_VBD given_VBN on_IN what_WP foods_NNS to_TO eat_VB (_( fresh_JJ
          fruits_NNS ,_, salads_NNS ,_, raw_JJ vegetables_NNS ,_, carrot_NN juice_NN ,_, nuts_NNS ,_,
          seeds_NNS ,_, whole_JJ grain_NN products_NNS ,_, tubers_NNS ,_, flax_NN seed_NN oil_NN ,_, extra_JJ
          virgin_JJ olive_JJ oil_NN )_) what_WP foods_NNS to_TO avoid_VB (_( alcohol_NN ,_, caffeine_NN ,_,
          foods_NNS containing_VBG refined_VBN sugar_NN ,_, corn_NN syrup_NN ,_, refined_VBN
          and_CC /_NN or_CC hydrogenated_JJ oil_NN ,_, refined_VBN flour_NN ,_, dairy_NN ,_, eggs_NNS ,_, and_CC
          all_DT meat_NN )_) and_CC how_WRB to_TO prepare_VB freshly_RB extracted_VBN carrot_NN
          juice_NN with_IN the_DT supplied_VBN Champion_NNP juicer_NN (_( Plastaket_NNP Mfg_NNP ._.
          Co_NNP ._. Inc_NNP ._. ,_, Lodi_NNP ,_, CA_NNP )_) ._. Subjects_NNP were_VBD given_VBN a_DT 2_CD -_: month_NN supply_NN
          of_IN dehydrated_JJ barley_NN grass_NN juice_NN powder_NN (_( Barleygreen_NNP )_) and_CC
          a_DT blend_NN of_IN laxative_NN herbs_NNS and_CC psyllium_NN seed_NN (_( Herbal_NNP
          Fiberblend_NNP )_) (_( AIM_NNP International_NNP ,_, Nampa_NNP ,_, ID_NNP )_) ,_, with_IN
          instruction_NN to_TO ask_VB for_IN more_JJR when_WRB this_DT supply_NN was_VBD
          finished_VBN ._. Subjects_NNP were_VBD encouraged_VBN to_TO attend_VB a_DT live_JJ
          motivational_NN presentation_NN of_IN the_DT basis_NN of_IN the_DT Hallelujah_NNP
          Diet_NNP to_TO reorient_NN their_PRP$ thinking_VBG about_IN food_NN and_CC health_NN ._. A_DT
          video_NN was_VBD available_JJ for_IN those_DT subjects_NNS that_WDT did_VBD not_RB
          attend_VB the_DT presentation_NN ._. No_DT regular_JJ support_NN meetings_NNS were_VBD
          scheduled_VBN for_IN motivational_NN encouragement_NN after_IN this_DT
          initial_JJ presentation_NN ,_, as_IN this_DT might_MD make_VB the_DT results_NNS less_RBR
          applicable_JJ to_TO the_DT general_JJ population_NN ._.
        
        
          Main_JJ outcome_NN measures_NNS
          Physical_JJ performance_NN measures_NNS ,_, as_IN detailed_VBN by_IN
          Mannerkorpi_NNP ,_, et_CC al_NN ._. [_NN 16_CD ]_NN ,_, were_VBD collected_VBN at_IN the_DT
          beginning_NN and_CC end_NN of_IN the_DT study_NN ._. 12_CD measures_NNS were_VBD used_VBN ._.
          These_DT were_VBD shoulder_NN pain_NN at_IN rest_NN ,_, range_NN of_IN active_JJ motion_NN
          abduction_NN and_CC flexion_NN ,_, shoulder_NN pain_NN on_IN motion_NN ,_, hand_NN to_TO
          neck_NN ,_, hand_NN to_TO scapula_NN ,_, isometric_JJ shoulder_NN endurance_NN ,_, neck_NN
          rotation_NN ,_, hand_NN grip_NN strength_NN ,_, flexibility_NN of_IN the_DT low_NN back_RB
          and_CC hamstrings_NNS using_VBG the_DT sit-and-reach_JJ method_NN ,_, chair_NN test_NN
          (_( number_NN of_IN times_NNS a_DT subject_NN could_MD stand_VB up_RB in_IN a_DT minute_NN )_) ,_,
          and_CC a_DT six-minute_JJ walk_NN ._. All_DT of_IN these_DT measures_NNS were_VBD taken_VBN
          by_IN the_DT same_JJ physical_JJ therapist_NN (_( SL_NNP )_) ._. Along_IN with_IN these_DT
          objective_NN tests_NNS ,_, subjects_NNS were_VBD asked_VBN to_TO report_VB their_PRP$
          health_NN status_NN using_VBG the_DT Fibromyalgia_NNP Impact_NNP Questionnaire_NNP
          [_NN 17_CD ]_NN ,_, the_DT SF-_NNP 36_CD short_JJ form_NN health_NN survey_NN [_NN 18_CD ]_NN ,_, and_CC
          a_DT Quality_NNP of_IN Life_NNP Survey_NNP [_NN 19_CD ]_NN ._. The_DT SF-_NNP 36_CD has_VBZ been_VBN
          widely_RB used_VBN to_TO record_VB how_WRB a_DT person_NN perceives_VBZ his_PRP$ or_CC her_PRP$
          own_JJ health_NN status_NN ._. The_DT quality_NN of_IN life_NN survey_NN queries_VBZ the_DT
          subject_NN about_IN 16_CD different_JJ aspects_NNS of_IN life_NN with_IN a_DT scale_NN
          from_IN 0_CD to_TO 7_CD for_IN each_DT question_NN ._. These_DT questionnaires_NNS were_VBD
          self-administered_JJ at_IN 0_CD ,_, 2_CD ,_, 4_CD ,_, and_CC 7_CD months_NNS ._.
          A_DT food_NN frequency_NN questionnaire_NN (_( FFQ_NNP )_) ,_, designed_VBN to_TO
          include_VB commonly_RB eaten_VBN foods_NNS while_IN following_VBG the_DT
          Hallelujah_NNP Diet_NNP ,_, was_VBD also_RB self-administered_JJ at_IN 2_CD ,_, 4_CD ,_, and_CC
          7_CD months_NNS ._. The_DT FFQ_NNP administered_VBN at_IN 2_CD months_NNS was_VBD analyzed_VBN
          using_VBG The_DT Food_NNP Processor_NNP ,_, version_NN 7_CD ._. 40_CD (_( ESHA_NNP Research_NNP ,_,
          Eugene_NNP ,_, OR_NNP )_) ._.
        
        
          Statistics_NNS
          The_DT FIQ_NNP ,_, QOL_NNP ,_, and_CC SF-_NNP 36_CD surveys_NNS were_VBD analyzed_VBN by_IN
          repeated_VBN measures_NNS analysis_NN of_IN variance_NN ._. Differences_NNS
          between_IN time_NN points_NNS were_VBD calculated_VBN using_VBG the_DT Bonferroni_NNP
          comparison_NN ._. A_DT subgroup_NN of_IN 20_CD of_IN the_DT participants_NNS was_VBD used_VBN
          that_WDT reported_VBD in_IN the_DT beginning_NN ,_, end_NN ,_, and_CC either_CC 2_CD or_CC 4_CD
          months_NNS into_IN the_DT trial_NN ._. The_DT physical_JJ performance_NN measures_NNS
          were_VBD analyzed_VBN by_IN the_DT student_NN 's_POS paired_VBN t-test_JJ ._. 18_CD subjects_NNS
          gave_VBD initial_JJ and_CC final_JJ physical_JJ performance_NN measures_NNS ._. A_DT
          significance_NN level_NN less_JJR than_IN 0_CD ._. 05_CD was_VBD considered_VBN
          statistically_RB significant_JJ ._.
          Responders_NNP and_CC non-responders_JJ were_VBD initially_RB
          distinguished_VBN using_VBG the_DT FIQ_NNP score_NN ._. If_IN a_DT subject_NN reported_VBD
          at_IN least_JJS a_DT 10_CD -_: point_NN improvement_NN in_IN their_PRP$ initial_JJ and_CC
          final_JJ FIQ_NNP score_NN ,_, then_RB that_IN subject_NN was_VBD classified_VBN as_IN a_DT
          responder_NN ._. A_DT 10_CD -_: point_NN improvement_NN in_IN the_DT FIQ_NNP correlated_JJ
          with_IN statistically_RB significant_JJ improvements_NNS in_IN measures_NNS
          of_IN physical_JJ performance_NN ,_, QOLS_NNP scores_NNS ,_, and_CC SF-_NNP 36_CD
          scores_NNS ._.
        
      
      
        Results_NNS
        
          Subjects_NNP
          30_CD subjects_NNS participated_VBD in_IN this_DT study_NN ,_, 28_CD female_JJ ,_, 2_CD
          male_JJ ._. All_DT subjects_NNS had_VBD been_VBN previously_RB diagnosed_VBN with_IN
          fibromyalgia_NN by_IN a_DT rheumatologist_NN ,_, but_CC not_RB all_DT subjects_NNS
          currently_RB had_VBD 11_CD or_CC more_RBR positive_JJ tender_NN points_NNS ._. All_DT
          subjects_NNS had_VBD symptoms_NNS which_WDT they_PRP attributed_VBD to_TO FMS_NNP ._.
          Compliance_NNP of_IN subjects_NNS was_VBD monitored_VBN by_IN self-reported_JJ
          food_NN intakes_NNS on_IN a_DT food_NN frequency_NN questionnaire_NN ,_, and_CC by_IN
          requests_NNS for_IN more_RBR dehydrated_JJ barley_NN grass_NN juice_NN ._.
          Approximately_RB a_DT two-month_JJ supply_NN was_VBD initially_RB given_VBN to_TO
          each_DT subject_NN ,_, with_IN instructions_NNS to_TO call_VB and_CC ask_VB for_IN more_JJR
          when_WRB their_PRP$ supply_NN ran_VBD out_RP ._.
          20_CD subjects_NNS (_( 15_CD of_IN whom_WP are_VBP classified_VBN as_IN responders_NNS )_)
          returned_VBD surveys_NNS at_IN the_DT beginning_NN ,_, end_NN ,_, and_CC either_CC 2_CD or_CC 4_CD
          months_NNS ._. Detailed_NNP results_NNS for_IN the_DT self-reported_JJ
          questionnaires_NNS (_( FIQ_NNP ,_, SF-_NNP 36_CD ,_, QOLS_NNP )_) here_RB are_VBP reported_VBN for_IN
          this_DT subgroup_NN ._. Response_NNP (_( responder_NN or_CC non-responder_JJ )_) to_TO
          the_DT dietary_JJ intervention_NN is_VBZ reported_VBN based_VBN on_IN all_DT 30_CD
          subjects_NNS according_VBG to_TO the_DT intention_NN to_TO treat_VB principle_NN ._.
          Analysis_NNP shows_VBZ there_EX were_VBD no_DT significant_JJ differences_NNS in_IN
          gathered_VBD data_NNS between_IN the_DT whole_JJ group_NN and_CC this_DT
          sub-group_JJ ._.
        
        
          Dietary_NNP intake_NN
          Food_NN frequency_NN questionnaires_NNS were_VBD collected_VBN from_IN 26_CD
          participants_NNS ._. Nutrient_NNP intakes_NNS ,_, based_VBN on_IN the_DT FFQ_NNP
          administered_VBN at_IN 2_CD months_NNS ,_, are_VBP reported_VBN in_IN Table_NNP 1_CD ._. Diet_NNP
          percentages_NNS ,_, on_IN an_DT energy_NN basis_NN ,_, were_VBD 24_CD percent_NN fat_JJ ,_, 65_CD
          percent_NN carbohydrate_NN ,_, and_CC 11_CD percent_NN protein_NN ._.
          Participants_NNS reported_VBD drinking_VBG 2_CD -_: 4_CD 240_CD ml_NN servings_NNS of_IN
          carrot_NN juice_NN daily_JJ ,_, so_IN that_IN the_DT mean_JJ intake_NN of_IN
          beta-carotene_JJ was_VBD 52_CD mg_NN /_NN day_NN ._. Several_JJ participants_NNS
          reported_VBD less_JJR consumption_NN of_IN carrot_NN juice_NN at_IN 7_CD months_NNS
          than_IN at_IN 2_CD months_NNS ._. The_DT dehydrated_JJ barley_NN grass_NN juice_NN was_VBD
          consumed_VBN by_IN all_DT but_CC 2_CD subjects_NNS who_WP reported_VBD immediate_JJ
          nausea_NN upon_IN consumption_NN of_IN the_DT powder_NN ._. Flax_NNP seed_NN oil_NN was_VBD
          consumed_VBN by_IN 23_CD of_IN 26_CD participants_NNS so_IN that_IN the_DT mean_JJ intake_NN
          of_IN n-_NN 3_CD fatty_NN acids_NNS was_VBD about_IN 6_CD g_SYM /_NN day_NN ._. Fresh_NNP fruit_NN and_CC
          salads_NNS ,_, based_VBD mostly_RB on_IN leaf_NN lettuce_NN and_CC dark_JJ leafy_JJ
          greens_NNS rather_RB than_IN head_NN lettuce_NN ,_, were_VBD consumed_VBN daily_RB ._. The_DT
          high_JJ intakes_NNS of_IN fruits_NNS and_CC vegetables_NNS resulted_VBD in_IN high_JJ
          intakes_NNS of_IN fiber_NN ,_, vitamin_NN C_NNP ,_, folate_NN ,_, potassium_NN ,_, and_CC
          magnesium_NN ._. Animal_NNP product_NN consumption_NN was_VBD very_RB low_JJ ,_,
          especially_RB intakes_NNS of_IN meat_NN ,_, poultry_NN ,_, and_CC fish_NN ._. Intakes_NNP
          were_VBD mainly_RB from_IN once_RB weekly_JJ to_TO none_NN ,_, resulting_VBG in_IN low_JJ
          intakes_NNS of_IN fat_JJ ,_, cholesterol_NN ,_, vitamins_NNS B_NNP 12_CD and_CC D_NNP ,_, and_CC
          zinc_NN ._. Soft_NNP drink_NN intake_NN was_VBD reported_VBN in_IN 11_CD subjects_NNS ,_,
          demonstrating_VBG willingness_NN to_TO report_VB truthfully_RB ._. Only_RB 3_CD
          subjects_NNS reported_VBD consuming_NN more_JJR than_IN a_DT 340_CD ml_NN serving_VBG
          per_IN week_NN ._.
        
        
          Physical_JJ performance_NN
          Eighteen_CD subjects_NNS were_VBD followed_VBN up_RP after_IN completion_NN of_IN
          the_DT study_NN (_( see_VB Table_NNP 2_LS )_) ._. Results_NNS are_VBP only_RB reported_VBN for_IN
          these_DT 18_CD subjects_NNS ,_, 13_CD of_IN whom_WP were_VBD classified_VBN as_IN
          responders_NNS ,_, Initial_JJ values_NNS were_VBD very_RB similar_JJ to_TO values_NNS
          reported_VBN by_IN Mannerkorpi_NNP et_CC al_NN ._. [_NN 16_CD ]_NN ._. Significant_JJ
          improvements_NNS (_( P_NN <_NN 0_CD ._. 03_CD ,_, paired_VBN t-test_JJ )_) in_IN these_DT 18_CD
          subjects_NNS were_VBD seen_VBN in_IN shoulder_NN pain_NN at_IN rest_NN and_CC after_IN
          motion_NN ,_, abduct_NN range_NN of_IN motion_NN of_IN shoulder_NN ,_, flexibility_NN
          (_( sit_VB and_CC reach_VB )_) ,_, chair_NN test_NN ,_, and_CC 6_CD -_: minute_NN walk_NN ._. Neck_NNP
          rotation_NN (_( left_VBD only_RB )_) was_VBD also_RB significantly_RB improved_VBN ._.
          Hand_NNP grip_NN strength_NN decreased_VBD significantly_RB in_IN right_JJ hand_NN
          and_CC decreased_VBD to_TO a_DT lesser_JJR extent_NN in_IN the_DT left_NN hand_NN ._.
          Isometric_NNP shoulder_NN endurance_NN showed_VBD no_DT change_NN ._.
        
        
          FIQ_NNP
          The_DT FIQ_NNP is_VBZ a_DT survey_NN designed_VBN specifically_RB to_TO measure_VB
          the_DT impact_NN of_IN fibromyalgia_NN on_IN a_DT person_NN 's_POS life_NN ._. After_IN two_CD
          months_NNS the_DT mean_NN FIQ_NNP score_NN had_VBD fallen_VBN from_IN 51_CD points_NNS to_TO 34_CD
          points_NNS and_CC decreased_VBD further_JJ to_TO 28_CD points_NNS at_IN seven_CD
          months_NNS ,_, (_( n_NN =_SYM 20_CD at_IN each_DT time_NN point_NN )_) ._. This_DT is_VBZ a_DT 33_CD %_NN
          improvement_NN after_IN 2_CD months_NNS ,_, and_CC a_DT 46_CD %_NN improvement_NN after_IN 7_CD
          months_NNS ._. The_DT histogram_NN in_IN Figure_NN 1_CD of_IN the_DT FIQ_NNP score_NN shows_VBZ a_DT
          decrease_NN in_IN the_DT scores_NNS as_IN the_DT trial_NN progressed_VBD ._.
          There_EX was_VBD a_DT significant_JJ trend_NN (_( all_DT P_NN <_NN 0_CD ._. 05_CD )_) for_IN
          improvement_NN in_IN all_DT scales_NNS (_( see_VB Table_NNP 3_LS )_) ._. There_EX were_VBD
          significant_JJ improvements_NNS (_( P_NN <_NN 0_CD ._. 05_CD with_IN Bonferroni_NNP
          correction_NN )_) in_IN all_DT of_IN the_DT FIQ_NNP sub-scales_JJ from_IN 0_CD -_: 7_CD months_NNS ,_,
          and_CC almost_RB all_DT of_IN the_DT sub-scales_JJ from_IN 0_CD -_: 2_CD months_NNS (_( "_'' work_NN
          missed_VBD "_'' and_CC "_'' days_NNS feeling_NN good_JJ "_'' being_VBG the_DT exceptions_NNS )_)
          (_( see_VB Table_NNP 3_LS )_) ._.
        
        
          QOL_NNP
          Quality_NNP of_IN life_NN improved_VBN during_IN this_DT 7_CD -_: month_NN trial_NN ,_,
          with_IN the_DT composite_JJ score_NN rising_VBG from_IN an_DT initial_JJ 3_CD ._. 9_CD to_TO
          4_CD ._. 7_CD at_IN 2_CD months_NNS and_CC 4_CD ._. 9_CD at_IN 7_CD months_NNS (_( n_NN =_SYM 20_CD each_DT time_NN
          point_NN ,_, P_NN for_IN trend_NN <_NN 1_CD E-_NNP 6_CD )_) ,_, on_IN a_DT scale_NN of_IN 0_CD to_TO 7_CD ,_, with_IN
          7_CD being_VBG a_DT delighted_JJ quality_NN of_IN life_NN ._. There_EX were_VBD
          significant_JJ differences_NNS between_IN initial_JJ and_CC 2_CD month_NN
          scores_NNS ,_, and_CC initial_JJ and_CC 7_CD month_NN scores_NNS ,_, but_CC not_RB between_IN 2_CD
          and_CC 7_CD month_NN scores_NNS (_( P_NN <_NN 0_CD ._. 05_CD with_IN Bonferroni_NNP
          correction_NN )_) ._. The_DT biggest_JJS impact_NN was_VBD seen_VBN in_IN active_JJ
          recreation_NN ,_, health_NN ,_, socializing_VBG ,_, and_CC participation_NN in_IN
          organizations_NNS ._.
        
        
          SF-_NNP 36_CD
          The_DT SF-_NNP 36_CD health_NN survey_NN breaks_NNS down_RB health_NN into_IN 8_CD
          sub-headings_JJ ._. These_DT areas_NNS are_VBP physical_JJ functioning_NN ,_, role_NN
          physical_JJ ,_, bodily_RB pain_NN ,_, general_JJ health_NN ,_, vitality_NN ,_, social_JJ
          functioning_NN ,_, role_NN emotional_JJ ,_, and_CC mental_JJ health_NN (_( see_VB Table_NNP
          4_LS )_) ._. 7_CD of_IN these_DT 8_CD areas_NNS ,_, bodily_RB pain_NN being_VBG the_DT exception_NN ,_,
          showed_VBD significant_JJ improvement_NN (_( n_NN =_SYM 20_CD each_DT time_NN point_NN ,_,
          all_DT P_NN for_IN trend_NN <_NN 0_CD ._. 01_CD )_) ._. There_EX were_VBD significant_JJ
          differences_NNS for_IN these_DT 7_CD headings_NNS between_IN initial_JJ and_CC 2_CD
          month_NN scores_NNS ,_, except_IN for_IN general_JJ health_NN ,_, and_CC also_RB between_IN
          initial_JJ and_CC 7_CD month_NN scores_NNS ,_, but_CC not_RB between_IN 2_CD and_CC 7_CD month_NN
          scores_NNS (_( P_NN <_NN 0_CD ._. 05_CD with_IN Bonferroni_NNP correction_NN )_) ._.
          Norms_NNS for_IN the_DT general_JJ population_NN 's_POS responses_NNS to_TO the_DT
          SF-_NNP 36_CD questionnaire_NN have_VBP been_VBN published_VBN [_NN 20_CD ]_NN ._.
          Initially_RB ,_, the_DT mean_JJ score_NN for_IN all_DT of_IN the_DT SF-_NNP 36_CD scales_NNS
          were_VBD significantly_RB lower_JJR than_IN the_DT norms_NNS for_IN women_NNS ages_NNS
          45_CD -_: 54_CD ._. After_IN 7_CD months_NNS of_IN dietary_JJ intervention_NN 4_CD scales_NNS
          were_VBD no_RB longer_RB significantly_RB different_JJ from_IN the_DT norms_NNS ,_,
          showing_VBG marked_VBN improvement_NN (_( general_JJ health_NN ,_, vitality_NN ,_,
          role_NN emotional_JJ ,_, mental_JJ health_NN )_) (_( see_VB Table_NNP 4_LS )_) ._.
        
        
          Responders_NNP versus_CC non-responders_JJ
          A_DT 10_CD -_: point_NN improvement_NN in_IN the_DT FIQ_NNP score_NN was_VBD used_VBN to_TO
          distinguish_VB responders_NNS from_IN non-responders_JJ ._. 19_CD subjects_NNS
          were_VBD classified_VBN as_IN responders_NNS ,_, 8_CD as_IN non-responders_JJ ,_, and_CC 3_CD
          individuals_NNS did_VBD not_RB follow_VB through_IN on_IN initial_JJ
          evaluations_NNS ._. Mean_VB FIQ_NNP score_NN improvement_NN for_IN responders_NNS
          was_VBD 30_CD points_NNS ,_, with_IN a_DT range_NN from_IN 11_CD to_TO 62_CD points_NNS ._. Mean_VB
          FIQ_NNP score_NN decreased_VBN by_IN 3_CD ._. 6_CD points_NNS for_IN non-responders_JJ ,_,
          with_IN a_DT range_NN from_IN 3_CD ._. 5_CD to_TO -_: 14_CD ._. 6_CD points_NNS ._. The_DT responders_NNS '_POS
          SF-_NNP 36_CD scores_NNS at_IN 7_CD months_NNS for_IN all_DT scales_NNS except_IN bodily_RB
          pain_NN were_VBD no_RB longer_RB statistically_RB different_JJ from_IN norms_NNS
          for_IN women_NNS ages_NNS 45_CD -_: 54_CD ._. Responders_NNP to_TO the_DT dietary_JJ
          intervention_NN also_RB had_VBD significant_JJ improvements_NNS in_IN
          physical_JJ performance_NN and_CC QOL_NNP scores_NNS (_( data_NNS not_RB shown_VBN )_) ,_,
          while_IN non-responders_JJ had_VBD no_DT significant_JJ change_NN in_IN their_PRP$
          fibromyalgia_NN status_NN ._.
        
      
      
        Discussion_NNP
        The_DT connection_NN between_IN dietary_JJ and_CC lifestyle_NN habits_NNS with_IN
        chronic_JJ diseases_NNS has_VBZ become_VBN increasingly_RB strong_JJ in_IN the_DT past_JJ
        several_JJ years_NNS ._. Most_JJS of_IN the_DT research_NN has_VBZ been_VBN towards_IN the_DT
        prevention_NN of_IN chronic_JJ disease_NN rather_RB than_IN toward_IN its_PRP$
        treatment_NN ._.
        The_DT natural_JJ course_NN of_IN fibromyalgia_NN shows_VBZ that_IN symptoms_NNS
        are_VBP generally_RB the_DT same_JJ over_IN at_IN least_JJS 7_CD years_NNS [_NN 3_CD ]_NN ._. A_DT
        stable_JJ ,_, sharp_JJ reduction_NN in_IN symptoms_NNS in_IN seven_CD months_NNS ,_, as_IN we_PRP
        have_VBP reported_VBN here_RB ,_, is_VBZ a_DT definite_JJ alteration_NN of_IN the_DT natural_JJ
        history_NN of_IN fibromyalgia_NN ._.
        Group_NNP treatment_NN of_IN fibromyalgia_NN patients_NNS using_VBG a_DT
        multi-faceted_JJ approach_NN resulted_VBD in_IN a_DT 25_CD %_NN improvement_NN in_IN
        overall_JJ FIQ_NNP score_NN and_CC a_DT 5_CD ._. 2_CD cm_NN increase_NN in_IN sit_VB and_CC reach_VB
        flexibility_NN [_NN 21_CD ]_NN ._. This_DT study_NN resulted_VBD in_IN even_RB greater_JJR
        improvements_NNS with_IN a_DT 46_CD %_NN improvement_NN in_IN overall_JJ FIQ_NNP score_NN
        and_CC a_DT 6_CD ._. 1_CD cm_NN increase_NN in_IN sit-and-reach_JJ flexibility_NN ._. A_DT
        six-week_JJ exercise_NN and_CC education_NN program_NN produced_VBD a_DT total_JJ
        drop_NN in_IN 8_CD FIQ_NNP subscales_NNS of_IN 2_CD ._. 4_CD points_NNS [_NN 22_CD ]_NN ;_: these_DT same_JJ
        subscales_NNS in_IN this_DT study_NN decreased_VBN by_IN 23_CD ._. 9_CD points_NNS after_IN the_DT
        dietary_JJ intervention_NN reported_VBD here_RB ._. This_DT comparison_NN shows_VBZ
        that_DT education_NN and_CC exercise_NN are_VBP not_RB as_IN an_DT effective_JJ
        intervention_NN as_IN this_DT dietary_JJ intervention_NN ._.
        As_IN mentioned_VBN ,_, vegetarian_NN dietary_JJ intervention_NN of_IN
        fibromyalgia_NN has_VBZ been_VBN tested_VBN by_IN two_CD investigators_NNS ._. In_IN a_DT
        small_JJ study_NN of_IN 10_CD patients_NNS ,_, Hostmark_NNP et_CC al_NN [_NN 14_CD ]_NN found_VBD a_DT
        3_CD -_: week_NN vegetarian_NN diet_NN produced_VBD an_DT improvement_NN in_IN
        subjective_JJ well-being_NN ._. Increase_VB in_IN well-being_NN ,_, as_IN seen_VBN in_IN
        the_DT improvement_NN in_IN quality_NN of_IN life_NN ,_, FIQ_NNP ,_, and_CC SF-_NNP 36_CD scores_NNS ,_,
        was_VBD also_RB seen_VBN in_IN our_PRP$ study_NN ._. In_IN a_DT recent_JJ study_NN Kaartinen_NNP et_CC
        al_NN [_NN 15_CD ]_NN used_VBD a_DT strict_JJ "_'' living-foods_JJ "_'' pure_JJ vegetarian_NN diet_NN
        in_IN 3_CD -_: month_NN non-randomized_JJ ,_, controlled_VBN study_NN of_IN FMS_NNP ._.
        Investigators_NNS saw_VBD significant_JJ improvements_NNS in_IN pain_NN scores_NNS
        and_CC significantly_RB less_JJR morning_NN stiffness_NNS ,_, similar_JJ to_TO our_PRP$
        results_NNS ._. Apparently_RB the_DT diet_NN was_VBD difficult_JJ to_TO implement_VB and_CC
        no_DT subjects_NNS continued_VBD with_IN the_DT "_'' living-foods_JJ "_'' diet_NN ._.
        Symptoms_NNP returned_VBD upon_IN reverting_VBG back_RB to_TO a_DT more_RBR standard_JJ
        diet_NN ,_, showing_VBG even_RB more_RBR clearly_RB the_DT association_NN of_IN diet_NN and_CC
        FMS_NNP ._. Maintenance_NNP of_IN diets_NNS requiring_VBG more_JJR food_NN preparation_NN
        time_NN and_CC uncommon_JJ foods_NNS is_VBZ difficult_JJ ._. Since_IN the_DT diet_NN used_VBN
        here_RB is_VBZ mainly_RB based_VBN on_IN common_JJ foods_NNS the_DT long-term_JJ
        adherence_NN to_TO the_DT program_NN is_VBZ likely_JJ to_TO be_VB higher_JJR ._. Subjects_NNP
        learned_VBD which_WDT foods_NNS caused_VBD them_PRP the_DT most_JJS symptoms_NNS so_IN that_IN
        they_PRP avoided_VBD these_DT foods_NNS on_IN a_DT long-term_JJ basis_NN ._.
        Initial_JJ scores_NNS using_VBG the_DT SF-_NNP 36_CD health_NN survey_NN ,_, compared_VBN
        to_TO population_NN norms_NNS ,_, were_VBD very_RB similar_JJ to_TO those_DT reported_VBD
        elsewhere_RB [_NN 7_CD ]_NN ._. This_DT indicates_VBZ that_IN our_PRP$ fibromyalgia_NN
        subjects_NNS were_VBD very_RB similar_JJ to_TO other_JJ surveyed_VBN groups_NNS in_IN
        terms_NNS of_IN their_PRP$ health_NN status_NN ._. Initial_JJ FIQ_NNP scores_NNS are_VBP also_RB
        in_IN line_NN with_IN other_JJ studies_NNS [_NN 21_CD ]_NN ._. After_IN 7_CD months_NNS ,_, the_DT 19_CD
        subjects_NNS that_WDT responded_VBD to_TO the_DT diet_NN were_VBD no_RB longer_RB
        statistically_RB different_JJ from_IN the_DT general_JJ population_NN of_IN
        women_NNS aged_VBN 45_CD -_: 54_CD ,_, except_IN for_IN bodily_RB pain_NN ._. This_DT indicates_VBZ a_DT
        remarkable_JJ recovery_NN of_IN function_NN in_IN a_DT short_JJ period_NN of_IN
        time_NN ._.
        Self-reported_NNP pain_NN was_VBD significantly_RB reduced_VBN as_IN measured_VBN
        by_IN the_DT FIQ_NNP and_CC by_IN the_DT physical_JJ performance_NN measurements_NNS ,_,
        but_CC not_RB as_IN measured_VBN by_IN the_DT SF-_NNP 36_CD questionnaire_NN ._. Both_DT the_DT
        FIQ_NNP and_CC physical_JJ performance_NN measure_NN used_VBD a_DT visual_JJ analog_NN
        scale_NN from_IN 0_CD -_: 10_CD to_TO measure_VB pain_NN ,_, whereas_IN the_DT SF-_NNP 36_CD only_RB
        used_VBN 2_CD questions_NNS with_IN a_DT total_JJ range_NN of_IN 10_CD points_NNS to_TO measure_VB
        bodily_RB pain_NN ._. This_DT may_MD have_VB made_VBN the_DT SF-_NNP 36_CD a_DT less_RBR sensitive_JJ
        measure_NN of_IN bodily_RB pain_NN than_IN the_DT other_JJ two_CD measures_NNS ._.
        It_PRP was_VBD unclear_JJ whether_IN or_CC not_RB closer_JJR adherence_NN to_TO the_DT
        diet_NN by_IN the_DT non-responders_JJ would_MD have_VB resulted_VBN in_IN better_JJR
        success_NN ._. Without_IN rapid_JJ improvements_NNS a_DT few_JJ subjects_NNS lost_VBD
        motivation_NN and_CC adhered_VBD less_JJR to_TO the_DT diet_NN ,_, while_IN others_NNS saw_VBD
        positive_JJ results_NNS within_IN a_DT couple_NN of_IN weeks_NNS ,_, thus_RB encouraging_VBG
        them_PRP to_TO continue_VB faithfully_RB ._. The_DT basis_NN for_IN not_RB responding_VBG
        to_TO the_DT diet_NN may_MD have_VB been_VBN physiological_JJ rather_RB than_IN
        motivational_NN ._. Further_RB research_NN will_MD help_VB answer_VB this_DT
        question_NN ._.
        What_WP caused_VBD the_DT significant_JJ improvements_NNS seen_VBN in_IN this_DT
        intervention_NN study_NN ?_. There_EX is_VBZ likely_JJ a_DT synergy_NN of_IN both_DT
        physiological_JJ and_CC psychological_JJ factors_NNS ._. The_DT change_NN in_IN diet_NN
        gave_VBD the_DT subjects_NNS motivation_NN to_TO take_VB control_NN of_IN their_PRP$
        symptoms_NNS ,_, to_TO overcome_VB their_PRP$ disabilities_NNS and_CC inactivity_NN ._.
        People_NNS that_WDT believed_VBD that_IN a_DT change_NN in_IN their_PRP$ diet_NN would_MD
        improve_VB their_PRP$ symptoms_NNS were_VBD attracted_VBN to_TO this_DT study_NN ._. The_DT
        effect_NN of_IN expecting_VBG a_DT positive_JJ result_NN was_VBD not_RB measured_VBN ,_, but_CC
        it_PRP certainly_RB was_VBD beneficial_JJ to_TO the_DT subjects_NNS ._.
        Some_DT aspects_NNS of_IN the_DT new_JJ diet_NN also_RB improve_VB fatigue_NN and_CC
        sleep_VB patterns_NNS ,_, so_IN that_IN overwhelming_JJ fatigue_NN did_VBD not_RB
        squelch_VBP subjects_NNS '_POS newfound_NN motivation_NN ._. Subjects_NNP could_MD begin_VB
        an_DT upward_JJ cycle_NN out_IN of_IN their_PRP$ FMS_NNP symptoms_NNS ,_, rather_RB
        continuing_VBG the_DT downward_JJ trend_NN toward_IN further_JJ disability_NN ,_,
        chronic_JJ pain_NN ,_, and_CC depression_NN ._.
        Intakes_NNP of_IN fats_NNS ,_, protein_NN ,_, fiber_NN ,_, several_JJ vitamins_NNS ,_,
        including_VBG the_DT antioxidants_NNS vitamin_NN C_NNP ,_, vitamin_NN E_NNP ,_, and_CC
        beta-carotene_JJ ,_, and_CC minerals_NNS (_( especially_RB magnesium_NN ,_,
        potassium_NN ,_, and_CC zinc_NN )_) are_VBP significantly_RB different_JJ from_IN the_DT
        general_JJ population_NN 's_POS dietary_JJ intake_NN (_( see_VB Table_NNP 1_LS )_) ,_, so_IN it_PRP is_VBZ
        difficult_JJ to_TO single_VB out_IN which_WDT factors_NNS were_VBD most_RBS important_JJ
        in_IN producing_VBG the_DT dramatic_JJ improvements_NNS seen_VBN in_IN this_DT study_NN ._.
        The_DT improvement_NN is_VBZ likely_JJ the_DT synergistic_JJ result_NN of_IN several_JJ
        factors_NNS ._. It_PRP is_VBZ unlikely_JJ that_IN a_DT single_JJ factor_NN or_CC a_DT dietary_JJ
        supplement_NN will_MD be_VB able_JJ to_TO reproduce_VB the_DT results_NNS generated_VBN
        by_IN an_DT overall_JJ dietary_JJ change_NN ._.
        Though_IN the_DT FFQ_NNP used_VBD in_IN this_DT study_NN has_VBZ not_RB been_VBN validated_JJ
        rigorously_RB ,_, a_DT comparison_NN to_TO 7_CD -_: day_NN semi-quantitative_JJ dietary_JJ
        intake_NN of_IN people_NNS following_VBG the_DT same_JJ Hallelujah_NNP Diet_NNP
        (_( unpublished_JJ data_NNS )_) showed_VBD that_IN ,_, on_IN an_DT energy_NN basis_NN ,_, the_DT
        only_RB significant_JJ differences_NNS between_IN nutrient_NN intakes_NNS
        reported_VBD here_RB and_CC in_IN that_DT survey_NN were_VBD for_IN fiber_NN and_CC vitamin_NN
        A_DT ._. So_RB ,_, it_PRP appears_VBZ that_IN the_DT FFQ_NNP captured_VBD nutrient_NN intakes_NNS
        satisfactorily_RB ._.
        Our_PRP$ study_NN had_VBD several_JJ limitations_NNS ._. First_LS ,_, because_IN all_DT of_IN
        the_DT subjects_NNS did_VBD not_RB currently_RB meet_VB the_DT diagnosis_NN criteria_NNS
        of_IN FMS_NNP ,_, the_DT results_NNS cannot_NN be_VB compared_VBN directly_RB with_IN other_JJ
        studies_NNS ._. It_PRP 's_VBZ possible_JJ ,_, but_CC cannot_NN be_VB proven_VBN here_RB ,_, that_IN
        greater_JJR improvement_NN would_MD have_VB been_VBN seen_VBN with_IN people_NNS who_WP
        were_VBD experiencing_VBG more_JJR pain_NN ._. It_PRP 's_VBZ also_RB possible_JJ that_IN
        subjects_NNS with_IN less_RBR severe_JJ pain_NN were_VBD able_JJ to_TO improve_VB
        quicker_JJR ._. Equal_NNP percentages_NNS of_IN subjects_NNS with_IN more_JJR than_IN 11_CD
        painful_JJ tender_NN points_NNS were_VBD found_VBN among_IN responders_NNS and_CC
        non-responders_JJ ._.
        Second_JJ ,_, as_IN an_DT unblinded_JJ observational_NN study_NN there_EX was_VBD no_DT
        direct_JJ comparison_NN with_IN a_DT control_NN group_NN ._. Many_JJ historical_JJ
        controls_NNS were_VBD available_JJ and_CC the_DT natural_JJ ,_, chronic_JJ course_NN of_IN
        FMS_NNP is_VBZ well_RB described_VBN ._. However_RB ,_, the_DT results_NNS would_MD certainly_RB
        be_VB stronger_JJR if_IN an_DT active_JJ control_NN group_NN was_VBD included_VBN ._.
        Another_DT limitation_NN was_VBD the_DT size_NN of_IN the_DT treatment_NN group_NN ._.
        Though_IN the_DT subjects_NNS here_RB seemed_VBD to_TO be_VB representative_NN of_IN
        people_NNS with_IN FMS_NNP ,_, it_PRP is_VBZ not_RB certain_JJ that_IN the_DT same_JJ results_NNS
        would_MD be_VB seen_VBN in_IN a_DT large_JJ study_NN ._. These_DT results_NNS should_MD be_VB
        reproduced_VBD and_CC extended_VBN in_IN a_DT larger_JJR ,_, controlled_VBN trial_NN ._.
      
      
        Conclusions_NNP
        In_IN summary_NN ,_, a_DT diet_NN intervention_NN using_VBG a_DT mostly_RB raw_JJ ,_, pure_JJ
        vegetarian_NN diet_NN produced_VBD dramatic_JJ improvements_NNS in_IN FMS_NNP
        symptoms_NNS ._. 19_CD of_IN 30_CD participants_NNS responded_VBD very_RB favorably_RB to_TO
        the_DT intervention_NN ,_, seeing_VBG marked_VBN improvement_NN in_IN all_DT FMS_NNP
        symptoms_NNS ._. This_DT dietary_JJ intervention_NN shows_VBZ that_IN many_JJ
        fibromyalgia_NN subjects_NNS can_MD be_VB helped_VBN even_RB without_IN
        understanding_VBG the_DT full_JJ cause_NN of_IN their_PRP$ symptoms_NNS ._. Further_RB
        controlled_VBN studies_NNS are_VBP needed_VBN to_TO reproduce_VB and_CC extend_VB the_DT
        results_NNS obtained_VBN here_RB to_TO see_VB if_IN this_DT dietary_JJ intervention_NN
        is_VBZ a_DT viable_JJ adjunctive_JJ therapy_NN for_IN managing_VBG fibromyalgia_NN in_IN
        a_DT clinical_JJ setting_NN ._.
      
      
        Competing_VBG interests_NNS
        Michael_NNP Donaldson_NNP is_VBZ a_DT research_NN scientist_NN at_IN the_DT
        Hallelujah_NNP Acres_NNP Foundation_NNP ,_, a_DT foundation_NN for_IN
        investigations_NNS pertaining_VBG to_TO the_DT Hallelujah_NNP Diet_NNP ._. Funding_NNP
        for_IN this_DT study_NN was_VBD provided_VBN by_IN the_DT Hallelujah_NNP Acres_NNP
        Foundation_NNP ._. Michael_NNP Donaldson_NNP is_VBZ not_RB a_DT distributor_NN of_IN AIM_NNP
        products_NNS (_( Barleygreen_NNP and_CC Herbal_NNP Fiberblend_NNP )_) ,_, nor_CC does_VBZ he_PRP
        have_VB any_DT financial_JJ interests_NNS in_IN AIM_NNP ,_, International_NNP ._.
        Neal_NNP Speight_NNP has_VBZ no_DT competing_VBG interests_NNS ,_, financial_JJ or_CC
        otherwise_RB ._. Stephen_NNP Loomis_NNP has_VBZ no_DT competing_VBG interests_NNS ,_,
        financial_JJ or_CC otherwise_RB ._.
      
    
  
